supplements

Choline

Choline is an essential water-soluble nutrient critical for the structural integrity of cell membranes, the synthesis of the neurotransmitter acetylcholine, and systemic methyl group donation. It acts as a primary precursor to betaine, supporting the alternative liver remethylation pathway and systemic lipid metabolism. Adequate choline intake is vital for neurological development, optimal cognitive function, and the prevention of non-alcoholic fatty liver disease (NAFLD) through the facilitation of hepatic lipid transport.

schedule 12 min read update Updated April 3, 2026

Key Takeaways

  • Serves as the vital precursor for the synthesis of acetylcholine, a major neurotransmitter crucial for memory formation, learning, sustained attention, and muscle contraction.
  • Functions as a primary structural component of cell membranes via its incorporation into phosphatidylcholine and sphingomyelin, ensuring cellular integrity and facilitating proper intracellular signaling.
  • Acts as a major source of methyl groups through its irreversible oxidation to betaine in the liver, driving the remethylation of homocysteine and supporting the body's total epigenetic pool via interactions with the DNMT1 pathway.
  • Plays an essential, indispensable role in hepatic lipid metabolism; a deficiency rapidly leads to the accumulation of triglycerides in the liver (NAFLD) due to impaired synthesis and export of very-low-density lipoproteins (VLDL).
  • Demonstrates a critical necessity during pregnancy and fetal development, ensuring proper neural tube closure, facilitating fetal brain development, and influencing lifelong cognitive outcomes through epigenetic programming.
  • Interacts intimately with genetic variants, particularly the MTHFR polymorphism; individuals with compromised primary folate-dependent methylation rely heavily on choline-derived betaine to maintain systemic methylation capacity.

Basic Information

Name
Choline
Also Known As
2-hydroxy-N,N,N-trimethylethanaminiumvitamin B4 (historically)CDP-cholinealpha-GPCphosphatidylcholine
Category
Essential nutrient / Methyl donor
Bioavailability
The bioavailability of choline is highly dependent on its chemical form. Dietary phosphatidylcholine (found in eggs and meat) is well-absorbed but requires enzymatic cleavage in the gut before absorption. Free choline salts (e.g., choline bitartrate) are highly water-soluble and rapidly absorbed, though large doses can be degraded by gut bacteria into trimethylamine (TMA). Advanced supplemental forms, such as Citicoline (CDP-Choline) and Alpha-GPC, are designed to cross the blood-brain barrier more efficiently, providing superior central nervous system bioavailability and targeted cognitive benefits.
Half-Life
Choline operates within a complex systemic pool rather than exhibiting a simple plasma half-life. Once absorbed, it is rapidly incorporated into cellular membranes as phosphatidylcholine, oxidized to betaine in the liver, or utilized for acetylcholine synthesis. Therefore, its biological effects are sustained. Unused free choline is excreted by the kidneys, but the body possesses extensive conservation and recycling mechanisms, particularly during periods of dietary restriction.

Primary Mechanisms

Synthesis of acetylcholine via the enzyme choline acetyltransferase, supporting central and peripheral neurotransmission

Incorporation into phosphatidylcholine and sphingomyelin, ensuring the structural integrity and fluidity of all cellular membranes

Irreversible oxidation to betaine in the liver, driving the BHMT pathway for homocysteine remethylation

Support of the systemic epigenetic pool through the generation of SAMe, interacting heavily with DNMT1

Facilitation of hepatic lipid export through the obligate synthesis of VLDL particles

Modulation of bile acid production and liver health via the KLB-FGF19 signaling axis

Quick Safety Summary

Studied Doses

The Adequate Intake (AI) is established at 550 mg per day for adult men and 425 mg per day for non-pregnant adult women. For cognitive enhancement and clinical applications, supplemental doses of specific forms (like CDP-Choline or Alpha-GPC) typically range from 250 to 1,200 mg per day. The Tolerable Upper Intake Level (UL) is set at 3,500 mg per day for adults.

Contraindications

Trimethylaminuria (Fish Odor Syndrome), a rare genetic disorder where individuals cannot properly metabolize TMA; high choline intake exacerbates the severe body odor, Severe renal impairment, where excessive choline supplementation could theoretically burden clearance mechanisms, Parkinson's disease, where excessive systemic acetylcholine could theoretically exacerbate motor symptoms or interact poorly with anticholinergic medications, Bipolar disorder or severe clinical depression, as very high doses of choline have occasionally been linked to the exacerbation of depressive symptoms, Individuals with an established high risk for cardiovascular disease should be cautious with massive doses of free choline salts, due to the potential for excessive TMAO conversion by gut bacteria

Overview

Choline is a water-soluble essential nutrient that bridges the gap between a vitamin and a vital structural building block. While the human body possesses a limited capacity to synthesize choline de novo within the liver—via the phosphatidylethanolamine N-methyltransferase (PEMT) pathway—this endogenous production is wholly insufficient to meet human physiological demands, rendering dietary intake absolutely essential. Ubiquitously present in foods such as egg yolks, beef liver, and soybeans, choline serves three non-negotiable roles: it forms the phospholipid architecture of all cell membranes, acts as the direct precursor to the neurotransmitter acetylcholine, and functions as a primary methyl donor to support the body's vast epigenetic and metabolic networks. In 1998, the Institute of Medicine officially recognized choline as an essential nutrient, acknowledging its critical role in human health.

The neurological significance of choline is predicated on its conversion into acetylcholine by the enzyme choline acetyltransferase. Acetylcholine is a foundational neurotransmitter in both the central and peripheral nervous systems, governing processes ranging from memory consolidation and sustained focus to the stimulation of skeletal muscle contractions. The availability of systemic choline directly dictates the rate of acetylcholine synthesis. Consequently, highly bioavailable supplemental forms, such as Alpha-GPC and CDP-Choline, have been extensively investigated and utilized as nootropics to enhance cognitive vigilance, improve learning capacity, and mitigate the progression of age-related cognitive decline and mild dementias.

Beyond the nervous system, choline is an irreplaceable linchpin in hepatic lipid metabolism. In the liver, choline is utilized to synthesize phosphatidylcholine, an obligate structural component of very-low-density lipoproteins (VLDL). VLDL particles are responsible for transporting newly synthesized and dietary triglycerides out of the liver and into systemic circulation. In the absence of adequate choline, this transport mechanism completely fails, leading to the rapid, pathological accumulation of fat within hepatocytes. This mechanism explains why human dietary choline deficiency reliably and rapidly induces non-alcoholic fatty liver disease (NAFLD) and significant liver damage, a condition completely reversible upon the reintroduction of the nutrient.

Furthermore, choline serves as a massive reservoir of methyl groups, a role that intimately ties it to the body's epigenetic regulation. In the liver, choline is irreversibly oxidized into betaine, which then donates a methyl group to remethylate homocysteine into methionine. This betaine-homocysteine methyltransferase (BHMT) pathway provides a critical redundancy to the primary folate-dependent methylation cycle. This redundancy becomes exceptionally vital during periods of high metabolic demand, such as fetal development, or in individuals possessing genetic polymorphisms, such as the MTHFR variant, where primary folate processing is impaired. Through this pathway, choline ensures the constant supply of S-adenosylmethionine (SAMe), interacting directly with DNA methyltransferases to maintain the global epigenetic silencing and activation patterns essential for long-term health.

Core Health Impacts

  • Liver health and NAFLD prevention: Choline is absolutely mandatory for the export of lipids from the liver. It is a required building block for the synthesis of phosphatidylcholine, which is necessary to package triglycerides into very-low-density lipoproteins (VLDL). In states of human choline deficiency, the liver rapidly accumulates fat, leading to non-alcoholic fatty liver disease (NAFLD) and subsequent hepatic damage. Clinical studies confirm that restoring adequate choline intake completely reverses this diet-induced hepatic steatosis. Furthermore, dietary choline requirements are heavily influenced by the KLB-FGF19 axis, which regulates bile acid synthesis and overall liver metabolism.
  • Cognitive function and memory: As the direct precursor to acetylcholine, choline is fundamental to the neurological processes governing memory, learning, and attention. Observational studies consistently link higher dietary choline intake to superior cognitive performance and a reduced incidence of white matter hyperintensities in older adults. Supplementation with specific highly bioavailable forms, such as Alpha-GPC or CDP-Choline, has demonstrated efficacy in improving memory recall, enhancing executive function, and providing protective benefits against age-related cognitive decline and early-stage dementia.
  • Fetal development and maternal health: Choline demand increases dramatically during pregnancy and lactation to support rapid fetal tissue growth and brain development. Adequate maternal intake is essential for neural tube closure, operating in concert with folate. Moreover, animal and emerging human data suggest that high maternal choline intake during the perinatal period structurally alters the fetal hippocampus, enhancing lifelong memory capacity and providing resilience against cognitive stressors later in life through lasting epigenetic modifications.
  • Cardiovascular health and homocysteine: Through its oxidation to betaine in the liver, choline provides a critical alternative pathway for the remethylation of homocysteine into methionine. Elevated plasma homocysteine is a well-established independent risk factor for cardiovascular disease, endothelial dysfunction, and stroke. By driving this betaine-homocysteine methyltransferase (BHMT) pathway, adequate choline intake helps maintain homocysteine levels within the optimal physiological range, particularly in individuals with MTHFR genetic variants that impair the primary folate-dependent remethylation cycle.
  • Physical performance and muscle function: Because acetylcholine is the primary neurotransmitter at the neuromuscular junction, adequate choline availability is required for optimal muscle contraction and motor coordination. During prolonged, exhaustive endurance exercise, plasma choline levels can become significantly depleted, potentially contributing to central fatigue and a decline in physical performance. Targeted supplementation prior to exhaustive exercise may help maintain systemic choline pools, preserving maximal power output and delaying the onset of neuromuscular fatigue.
  • Epigenetic regulation and methylation: Choline is a foundational pillar of the human epigenetic landscape. The methyl groups provided by choline (via betaine) are ultimately used to generate S-adenosylmethionine (SAMe), the universal methyl donor for DNA and histones. Through its essential interaction with DNA methyltransferase 1 (DNMT1), choline availability dictates the proper maintenance of global DNA methylation patterns. Deficiencies in choline during critical developmental windows or throughout adulthood can lead to aberrant epigenetic silencing or activation, increasing susceptibility to metabolic and oncological diseases.
  • Metabolic syndrome and lipid profiles: Adequate systemic choline is necessary to maintain a healthy lipid profile. By facilitating the efficient export of triglycerides from the liver via VLDL, it prevents hepatic congestion and supports the subsequent clearance of lipids from the bloodstream. Disruptions in choline metabolism are strongly correlated with the development of metabolic syndrome, characterized by elevated circulating triglycerides, decreased HDL cholesterol, and systemic insulin resistance.

Gene Interactions

Key Gene Targets

DNMT1

Choline (via betaine) provides the critical methyl groups required for the synthesis of SAMe; DNMT1 strictly requires this SAMe supply to maintain the body's total epigenetic pool and ensure the proper inheritance of DNA methylation patterns during cell division.

KLB

Adequate choline supports optimal liver function, which is essential for the proper production of bile acids that are subsequently regulated by the KLB-FGF19 endocrine axis to control systemic lipid and glucose metabolism.

MTHFR

Individuals with MTHFR polymorphisms have compromised folate-dependent methylation; they therefore rely heavily on the oxidation of choline to betaine to support the alternative liver remethylation pathway and maintain healthy homocysteine and lipid metabolism.

Safety & Dosing

Contraindications

Trimethylaminuria (Fish Odor Syndrome), a rare genetic disorder where individuals cannot properly metabolize TMA; high choline intake exacerbates the severe body odor

Severe renal impairment, where excessive choline supplementation could theoretically burden clearance mechanisms

Parkinson's disease, where excessive systemic acetylcholine could theoretically exacerbate motor symptoms or interact poorly with anticholinergic medications

Bipolar disorder or severe clinical depression, as very high doses of choline have occasionally been linked to the exacerbation of depressive symptoms

Individuals with an established high risk for cardiovascular disease should be cautious with massive doses of free choline salts, due to the potential for excessive TMAO conversion by gut bacteria

Drug Interactions

Anticholinergic medications (e.g., scopolamine, specific antihistamines): Choline supplementation may directly antagonize the therapeutic effects of these drugs by increasing systemic acetylcholine

Cholinesterase inhibitors (e.g., donepezil, rivastigmine): Additive effects on acetylcholine levels; combining them may increase the risk of cholinergic side effects such as nausea or bradycardia

Methotrexate: This medication depletes folate pools, significantly increasing the body's reliance on the choline-betaine pathway for methylation; choline requirements may increase during therapy

Fibrate medications: Fibrates alter hepatic lipid metabolism and may alter the systemic requirement for phosphatidylcholine and free choline

Common Side Effects

Fishy body odor, resulting from the excessive bacterial conversion of unabsorbed free choline into trimethylamine (TMA) in the gut

Gastrointestinal distress, including nausea, vomiting, diarrhea, and increased salivation, particularly at very high doses

Excessive sweating and increased tear production (cholinergic side effects)

Mild, transient hypotension (low blood pressure) or lightheadedness following large acute boluses

Potential elevation of circulating TMAO (trimethylamine N-oxide), a biomarker tentatively linked to cardiovascular risk, though the clinical relevance remains debated

Studied Doses

The Adequate Intake (AI) is established at 550 mg per day for adult men and 425 mg per day for non-pregnant adult women. For cognitive enhancement and clinical applications, supplemental doses of specific forms (like CDP-Choline or Alpha-GPC) typically range from 250 to 1,200 mg per day. The Tolerable Upper Intake Level (UL) is set at 3,500 mg per day for adults.

Mechanism of Action

Acetylcholine Synthesis and Neurotransmission

The most immediate neurological mechanism of choline involves its role as the direct, obligate precursor for the synthesis of acetylcholine (ACh). Within the presynaptic terminals of cholinergic neurons, the enzyme choline acetyltransferase catalyzes the transfer of an acetyl group from acetyl-CoA to a free choline molecule, yielding acetylcholine. This neurotransmitter is subsequently packaged into vesicles and released into the synaptic cleft, where it binds to nicotinic and muscarinic receptors on target cells. In the central nervous system, abundant cholinergic innervation within the basal forebrain and hippocampus dictates processes of memory consolidation, sustained attention, and neuroplasticity. In the peripheral nervous system, acetylcholine is the exclusive neurotransmitter responsible for triggering skeletal muscle contractions at the neuromuscular junction. The rate of acetylcholine synthesis is directly dependent on the localized concentration of choline; therefore, systemic deficiencies or rapid depletion during extreme endurance events can lead to profound central fatigue and a precipitous decline in cognitive and motor performance.

Membrane Integrity and Phospholipid Synthesis

Choline serves as a foundational building block for cellular architecture. Through the cytidine diphosphate-choline (CDP-choline) pathway, also known as the Kennedy pathway, intracellular choline is sequentially phosphorylated and combined with lipid molecules to synthesize phosphatidylcholine (PC) and sphingomyelin. Phosphatidylcholine is the most abundant phospholipid in human cell membranes, typically comprising over 50 percent of the total phospholipid mass. It dictates membrane fluidity, structural integrity, and the proper embedding of trans-membrane receptors and ion channels. Furthermore, the hydrolysis of phosphatidylcholine by phospholipases generates vital intracellular secondary messengers, including diacylglycerol (DAG) and arachidonic acid, which propagate complex signal transduction cascades governing cellular proliferation, differentiation, and inflammatory responses.

Hepatic Lipid Transport and VLDL Assembly

Choline exercises critical control over systemic lipid metabolism primarily within the liver. Hepatocytes continuously synthesize triglycerides from excess dietary carbohydrates or incoming free fatty acids. To prevent the toxic accumulation of these lipids within the liver, they must be packaged into very-low-density lipoproteins (VLDL) and exported into systemic circulation for delivery to peripheral tissues. The assembly and secretion of a functional VLDL particle strictly require a substantial coating of phosphatidylcholine. If choline availability is insufficient to synthesize this requisite phosphatidylcholine, VLDL export halts completely. Consequently, triglycerides rapidly back up and accumulate within the hepatic parenchyma. This specific mechanistic failure is the direct, primary cause of diet-induced non-alcoholic fatty liver disease (NAFLD), illustrating why severe choline deficiency leads to profound liver damage within a matter of weeks.

Epigenetic Modulation via the BHMT Pathway

Beyond its structural and neurological roles, choline functions as an indispensable reservoir of methyl groups, wielding profound influence over the human epigenome. Within the liver and kidneys, choline is irreversibly oxidized into betaine (trimethylglycine). Betaine subsequently donates a methyl group to remethylate the toxic amino acid homocysteine back into methionine. This reaction is catalyzed by the enzyme betaine-homocysteine methyltransferase (BHMT). The resulting methionine is quickly converted into S-adenosylmethionine (SAMe), the universal methyl donor utilized by the entire body. Through this redundant pathway, choline bypasses the primary folate-dependent methylation cycle. The SAMe generated is strictly required by DNA methyltransferase 1 (DNMT1) to append methyl groups to cytosine residues on DNA, dictating gene silencing. Thus, the availability of dietary choline physically programs the epigenome, profoundly influencing gene expression patterns during fetal development and maintaining genomic stability throughout the human lifespan.

Clinical Evidence

Prevention and Reversal of NAFLD

The clinical requirement for human dietary choline was definitively established through parenteral nutrition studies. When patients were fed total parenteral nutrition completely devoid of choline, they universally developed severe hepatic steatosis (fatty liver) and elevated liver transaminases within weeks. The reintroduction of choline rapidly and completely reversed these pathological changes. This evidence underscores the absolute necessity of choline for VLDL export. Modern epidemiological data continuously reinforce this mechanism, demonstrating that individuals consuming diets low in choline are at a significantly heightened risk for developing non-alcoholic fatty liver disease (NAFLD). Furthermore, targeted supplementation with betaine—the direct oxidative metabolite of choline—has shown significant clinical efficacy in reducing hepatic fat content and improving liver enzymes in patients already suffering from established non-alcoholic steatohepatitis (NASH).

Large-scale observational research, notably the Framingham Offspring Cohort, has provided robust evidence connecting dietary choline to neurological health. The cohort data demonstrate that higher habitual choline intake is strongly associated with superior performance on verbal and visual memory tests. Furthermore, MRI imaging reveals that high-choline consumers exhibit a significantly lower incidence of white matter hyperintensities, which are physical markers of cerebrovascular disease and cognitive decline. In interventional settings, supplementation with highly bioavailable, brain-penetrant forms of choline—specifically CDP-Choline (Citicoline) and Alpha-GPC—has been extensively utilized to treat mild cognitive impairment and early-stage dementia. These forms reliably improve metrics of short-term memory, executive function, and behavioral regulation in older adults, leveraging both the enhanced synthesis of acetylcholine and the repair of neuronal membranes via phosphatidylcholine generation.

Maternal Health and Fetal Programming

The clinical importance of choline surges dramatically during pregnancy and lactation. Maternal choline supplies are heavily taxed to support the rapid division of fetal cells, the synthesis of new cellular membranes, and the proper development of the fetal brain. Operating in a complementary fashion with folate, adequate maternal choline is essential for the prevention of neural tube defects. Landmark clinical trials have demonstrated that supplementing pregnant women with high doses of choline (e.g., 930 mg daily) significantly enhances the information processing speed and visual memory capacity of the resulting infants. Animal models suggest this enhancement is a permanent structural upgrade, driven by epigenetic modifications that promote increased neurogenesis and enhanced plasticity within the fetal hippocampus, conferring lifelong resilience against cognitive decline.

Cardiovascular Health and Homocysteine Regulation

Elevated plasma homocysteine is an established, independent risk factor for endothelial dysfunction, atherosclerosis, and cardiovascular disease. Clinical trials consistently show that supplementation with large doses of choline or its derivative betaine significantly lowers fasting and post-methionine-load homocysteine levels. This reduction is achieved by robustly driving the hepatic BHMT remethylation pathway. This mechanism is of paramount clinical importance for the large percentage of the global population possessing the MTHFR C677T genetic polymorphism. These individuals suffer from reduced efficiency in the primary, folate-dependent methylation cycle. Clinical data confirm that individuals with this genetic variant require significantly higher dietary choline intake to maintain optimal homocysteine clearance and support the body’s total methylation demands, utilizing the choline-betaine pathway as a vital metabolic bypass.

Ergogenic Aid in Athletic Endurance

While the data regarding acute high-intensity exercise are mixed, clinical evidence supports the utility of choline supplementation during exhaustive endurance events. Prolonged physical exertion (e.g., marathons, triathlons) reliably depletes circulating plasma choline levels by up to 40 percent. This depletion limits the availability of precursor material for the continuous synthesis of acetylcholine at the neuromuscular junction, contributing to peripheral motor fatigue and an overall decline in central nervous system drive. Interventional studies indicate that strategic supplementation with choline prior to or during exhaustive exercise can successfully maintain plasma choline concentrations, potentially preserving maximal power output, delaying the onset of severe fatigue, and maintaining cognitive vigilance during the later stages of competition.

Dosing Guidance

The officially established Adequate Intake (AI) is 550 mg per day for adult men and 425 mg per day for non-pregnant adult women. However, numerous metabolic experts argue these levels are conservative, particularly for individuals with specific genetic variants (like MTHFR or PEMT polymorphisms). Pregnant and lactating women require 450 mg and 550 mg daily, respectively. For targeted cognitive enhancement, specific supplemental forms are required to efficiently cross the blood-brain barrier: Alpha-GPC is typically dosed between 300 and 600 mg daily, while CDP-Choline (Citicoline) is utilized at 250 to 500 mg daily. Standard choline salts, such as choline bitartrate, are less effective for cognitive purposes and are better suited for general metabolic support, though total daily doses should be divided to minimize the risk of gastrointestinal distress and the bacterial generation of fishy body odor (TMA).

Getting the Most from Choline

Dietary sources are exceptionally potent; consuming two whole eggs provides over half of the Adequate Intake for an adult, alongside highly bioavailable phosphatidylcholine.

Select the correct chemical form for your specific goals: utilize Alpha-GPC or CDP-Choline for cognitive enhancement and neurological support, and utilize phosphatidylcholine or dietary choline for liver health and systemic lipid management.

If you experience a noticeable "fishy" body odor while taking choline supplements, you are likely taking too much free choline salt at once; reduce the dose or switch to a phosphatidylcholine or Alpha-GPC preparation.

Because choline and folate functionally overlap in the methylation cycle, ensure adequate intake of methylfolate alongside choline to maximize cardiovascular protection and homocysteine clearance.

Individuals consuming strictly plant-based (vegan) diets are at a significantly higher risk of choline deficiency, as the most concentrated sources (eggs, liver, meat) are excluded, necessitating mindful dietary planning or supplementation.

Post-menopausal women undergo a drop in estrogen, which severely downregulates the body's internal (PEMT) production of choline, thereby increasing their reliance on strict dietary intake to prevent NAFLD.

Relevant Research Papers

Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.

Zeisel SH, da Costa KA (2009) Nutrition Reviews

A definitive and comprehensive review establishing the indispensable nature of choline in human health, detailing its critical roles in epigenetic methylation, liver lipid transport, and neurological development.

Buchman AL, Dubin MD, Moukarzel AA, et al. (1995) Journal of Parenteral and Enteral Nutrition

The landmark clinical study providing unequivocal proof of the human choline requirement, demonstrating that the absence of choline rapidly induces severe fatty liver disease, which is fully reversed upon its reintroduction.

Fischer LM, daCosta KA, Kwock L, et al. (2010) The American Journal of Clinical Nutrition

Highlights the profound intersection of endocrinology and genetics, showing that premenopausal women utilize estrogen to synthesize endogenous choline, whereas postmenopausal women and those with specific PEMT polymorphisms require significantly higher dietary intake.

Caudill MA, Strupp BJ, Muscalu L, et al. (2018) The FASEB Journal

A pivotal human clinical trial demonstrating that maternal choline supplementation at doses roughly twice the standard recommendation significantly accelerates information processing speed and cognitive function in the resulting infants.

Silveri MM, Dikan J, Salinas AJ, et al. (2008) NMR in Biomedicine

Utilizes advanced neuroimaging to prove that supplementation with CDP-Choline (Citicoline) actively increases the synthesis of vital structural phospholipids and boosts ATP bioenergetics within the human frontal lobe.

Abdelmalek MF, Angulo P, Jorgensen RA, et al. (2001) The American Journal of Gastroenterology

Demonstrates the clinical efficacy of the choline oxidation product, betaine, in significantly improving liver enzymes and clearing hepatic steatosis in patients suffering from non-alcoholic fatty liver disease.

Craig SA (2004) The American Journal of Clinical Nutrition

Provides a detailed mechanistic overview of how choline and its derivative betaine function as crucial systemic methyl donors, powerfully regulating homocysteine levels and providing cardiovascular protection.

Poly C, Massaro JM, Seshadri S, et al. (2011) The American Journal of Clinical Nutrition

A large-scale observational analysis confirming that higher habitual dietary intake of choline is robustly associated with superior memory performance and a physically healthier brain architecture in older adults.